242 related articles for article (PubMed ID: 33851006)
1. Effects of selective heart rate reduction with ivabradine on LV function and central hemodynamics in patients with chronic coronary syndrome.
Hohneck AL; Fries P; Stroeder J; Schneider G; Schirmer SH; Reil JC; Böhm M; Laufs U; Custodis F
Int J Cardiol Heart Vasc; 2021 Jun; 34():100757. PubMed ID: 33851006
[TBL] [Abstract][Full Text] [Related]
2. Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease.
Hohneck AL; Fries P; Ströder J; Schneider G; Wagenpfeil S; Schirmer SH; Böhm M; Laufs U; Custodis F
J Hypertens; 2019 May; 37(5):1023-1031. PubMed ID: 30672832
[TBL] [Abstract][Full Text] [Related]
3. Volume-time curve of cardiac magnetic resonance assessed left ventricular dysfunction in coronary artery disease patients with type 2 diabetes mellitus.
Xu HY; Yang ZG; Guo YK; Shi K; Liu X; Zhang Q; Jiang L; Xie LJ
BMC Cardiovasc Disord; 2017 Jun; 17(1):145. PubMed ID: 28583071
[TBL] [Abstract][Full Text] [Related]
4. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients.
Reil JC; Tardif JC; Ford I; Lloyd SM; O'Meara E; Komajda M; Borer JS; Tavazzi L; Swedberg K; Böhm M
J Am Coll Cardiol; 2013 Nov; 62(21):1977-1985. PubMed ID: 23933545
[TBL] [Abstract][Full Text] [Related]
5. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Management of Cirrhotic Cardiomyopathy.
Kaur H; Premkumar M
J Clin Exp Hepatol; 2022; 12(1):186-199. PubMed ID: 35068798
[TBL] [Abstract][Full Text] [Related]
7. Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction.
Reil JC; Hohl M; Reil GH; Granzier HL; Kratz MT; Kazakov A; Fries P; Müller A; Lenski M; Custodis F; Gräber S; Fröhlig G; Steendijk P; Neuberger HR; Böhm M
Eur Heart J; 2013 Sep; 34(36):2839-49. PubMed ID: 22833515
[TBL] [Abstract][Full Text] [Related]
8. Impact of type 2 diabetes mellitus on left ventricular diastolic function in patients with essential hypertension: evaluation by volume-time curve of cardiac magnetic resonance.
Yan WF; Gao Y; Zhang Y; Guo YK; Wang J; Jiang L; Li Y; Yang ZG
Cardiovasc Diabetol; 2021 Mar; 20(1):73. PubMed ID: 33766020
[TBL] [Abstract][Full Text] [Related]
9. LV mechanical dyssynchrony in heart failure with preserved ejection fraction complicating acute coronary syndrome.
Lee AP; Zhang Q; Yip G; Fang F; Liang YJ; Xie JM; Lam YY; Yu CM
JACC Cardiovasc Imaging; 2011 Apr; 4(4):348-57. PubMed ID: 21492809
[TBL] [Abstract][Full Text] [Related]
10. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
[TBL] [Abstract][Full Text] [Related]
11. Implications of pulse wave velocity and central pulse pressure in heart failure with reduced ejection fraction.
Kõre AC; Joonsalu T; Serg M; Pauklin P; Voitk J; Roose I; Eha J; Kampus P
Blood Press; 2024 Dec; 33(1):2359932. PubMed ID: 38819846
[TBL] [Abstract][Full Text] [Related]
12. Improved left ventricular diastolic filling in patients with coronary artery disease after percutaneous transluminal coronary angioplasty.
Bonow RO; Kent KM; Rosing DR; Lipson LC; Bacharach SL; Green MV; Epstein SE
Circulation; 1982 Dec; 66(6):1159-67. PubMed ID: 6216024
[TBL] [Abstract][Full Text] [Related]
13. Echo-Doppler assessment of arterial stiffness in pediatric patients with Kawasaki disease.
AlHuzaimi A; Al Mashham Y; Potts JE; De Souza AM; Sandor GG
J Am Soc Echocardiogr; 2013 Sep; 26(9):1084-9. PubMed ID: 23800509
[TBL] [Abstract][Full Text] [Related]
14. Effect of ivabradine on left ventricular diastolic function of patients with heart failure with preserved ejection fraction -IVA-PEF study.
Tanaka H; Yamauchi Y; Imanishi J; Hatani Y; Hayashi T; Hirata KI
J Cardiol; 2021 Jun; 77(6):641-644. PubMed ID: 33390289
[TBL] [Abstract][Full Text] [Related]
15. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
16. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.
Kitzman DW; Brubaker PH; Herrington DM; Morgan TM; Stewart KP; Hundley WG; Abdelhamed A; Haykowsky MJ
J Am Coll Cardiol; 2013 Aug; 62(7):584-92. PubMed ID: 23665370
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ivabradine on Left Ventricular Diastolic Function, Exercise Tolerance and Quality of Life in Patients With Heart Failure: A Systemic Review and Meta-Analysis of Randomized Controlled Trials.
Koroma TR; Samura SK; Cheng Y; Tang M
Cardiol Res; 2020 Feb; 11(1):40-49. PubMed ID: 32095195
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of elevated left ventricular end diastolic pressure in patients with preserved ejection fraction using cardiac magnetic resonance.
Gao C; Tao Y; Pan J; Shen C; Zhang J; Xia Z; Wan Q; Wu H; Gao Y; Shen H; Lu Z; Wei M
Eur Radiol; 2019 May; 29(5):2360-2368. PubMed ID: 30631923
[TBL] [Abstract][Full Text] [Related]
19. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure.
Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R
Am Heart J; 2013 Oct; 166(4):654-661.e6. PubMed ID: 24093844
[TBL] [Abstract][Full Text] [Related]
20. Effect of ivabradine in heart failure: a meta-analysis of heart failure patients with reduced versus preserved ejection fraction.
Tóth N; Soós A; Váradi A; Hegyi P; Tinusz B; Vágvölgyi A; Orosz A; Solymár M; Polyák A; Varró A; Farkas AS; Nagy N
Can J Physiol Pharmacol; 2021 Nov; 99(11):1159-1174. PubMed ID: 34636643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
